Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.
about
Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer.Molecular therapy for acute myeloid leukaemia.Inhibition of Cell Proliferation in an NRAS Mutant Melanoma Cell Line by Combining Sorafenib and α-Mangostin.Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia.Simple, Sensitive and Accurate Multiplex Detection of Clinically Important Melanoma DNA Mutations in Circulating Tumour DNA with SERS Nanotags.Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathwaysTreatment of NRAS-mutant melanoma.Advances in Immunotherapy for Melanoma: A Comprehensive Review.Key drivers of biomedical innovation in cancer drug discovery.Acute myeloid leukaemia.Targeted next generation sequencing in Chinese colorectal cancer patients guided anti-EGFR treatment and facilitated precision cancer medicine.Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma.Novel functional variants at the GWAS-implicated loci might confer risk to major depressive disorder, bipolar affective disorder and schizophrenia.Pak2 regulates myeloid-derived suppressor cell development in mice
P2860
Q27853104-CCF8D6EB-B162-438B-A053-67F15D6BA2B1Q33925672-9FE55166-C2AB-4020-89AB-D9D054287F3DQ36010837-C3474CEB-CA5C-41BC-A924-4B04AFABFB1CQ36214081-230EF53D-B8CD-4367-BCDA-366C43C44783Q37112945-CE7CD7A3-C54B-49E5-AB8B-E5A648BD4A0BQ37747447-211D6443-8474-46B0-92F7-B722D2ED0B20Q38386344-32A7954E-5D12-4E88-94E5-6CCEF2F9BC74Q38636521-6B920A90-545D-46D7-AB38-DD04A08CCBCEQ41768010-0F1823B2-75D9-4D3E-AC78-C68A39C33BD7Q47432401-7BD6B924-320F-4908-8FEB-094799EBD3F2Q49417294-E8565309-8F6E-4087-BB08-F91CB312505CQ52591043-219C68A0-B2B9-4E2D-8A55-A523C79C5100Q55317166-C3F05FB7-96AB-4650-8FE6-CB7B0BC02407Q57980065-9481E78F-7BDA-4353-B812-A63F9990CD8E
P2860
Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.
@ast
Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.
@en
Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.
@nl
type
label
Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.
@ast
Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.
@en
Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.
@nl
prefLabel
Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.
@ast
Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.
@en
Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.
@nl
P2860
P1476
Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.
@en
P2093
Douglas B Johnson
Jeffrey A Sosman
P2860
P304
P356
10.1158/1078-0432.CCR-13-3270
P407
P577
2014-06-03T00:00:00Z